EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
J. Distler(University Hospital of Zurich), Oliver Distler(University Hospital of Zurich), U Müller-Ladner(University of Giessen), F. Moritz, Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), Serena Guiducci(Azienda Ospedaliero-Universitaria Careggi), Yannick Allanore(Inserm), Roberto Giacomelli(Policlinico Umberto I), Andrea Gabrielli(Roma Tre University), Jérôme Avouac(Inserm), Alfiya Akhmetshina(Research Institute of Human Morphology), A Tyndall(University Hospital of Basel), Ulrich A. Walker(University Hospital of Basel)
Cited by 94
Related Papers
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501